Share Your Research, Maximize Your Social Impacts
Risk of myocarditis in patients with cancer treated with immune checkpoint inhibitors
Journal: Chronicles of Oncology (Vol.1, No. 1)Publication Date: 2018- 06-2
Authors : Matthew Kelling MS Michelle Dimza Samir Dalia MD;
Page : 1-4
Keywords : ;
Source : Download
Find it from : Google Scholar
Abstract
The field of oncology has changed immensely since the advent of immune checkpoint inhibitors (ICIs). Cancers, such as advanced melanoma, previously carried a prognosis of 8-10 months, now patients have a chance at remission.
Other Latest Articles
- A case of isolated metastasis to right level II cervical lymph node from intrahepatic cholangiocarcinoma
- The role of exosomes in diagnosis of non-haematological malignancies
- Breast and bone: A story of hidden similarities
- A successful strategy for achieving minimal cold ischemia time for Donation after Circulatory Death in Belfast City Hospital
- Modeling of the process of formation of the temperature field of the outer fence of the buildings in railway transport
Last modified: 2018-09-28 18:37:07